Wrinkle Treatment
The Sublime applicator uses a combination
of an infrared light source and bi-polar
radiofrequency to bulk heat the dermis and
affect dermal collagen in order to treat wrinkles.
The simultaneous combination of infrared and
bi-polar radiofrequency provides deep thermal
heating, up to 3 mm in depth.
Realistic Expectations:

Deep folds or dynamic wrinkles (wrinkles caused by chronic movement of underlying muscles) are not realistic treatment indications.
Patients wanting non-ablative treatment of wrinkles without down-time or high risk factors are suitable for Sublime treatment.
Results are observed gradually and a series of treatments (usually 3-5) are necessary.


  • Pacemaker or internal defibrillator.
  • Superficial metal or other implants in the treatment area.
  • Current or history of skin cancer, or current condition of any other type of cancer, or pre-malignant moles.
  • History of any kind of cancer.
  • Severe concurrent conditions, such as cardiac disorders.
  • Pregnancy or nursing.
  • Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
  • Diseases which may be stimulated by light at the wavelengths used, such as history of Systemic Lupus Erythematosus,
      Porphyria, and Epilepsy.
  • Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, may be treated only
      following a prophylacti regimen.
  • Poorly controlled endocrine disorders, such as Diabetes.
  • Any active condition in the treatment area, such as sores, Psoriasis, eczema and rash.
  • History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile skin.
  • History of bleeding coagulopathies, or use of anticoagulants with the exception of preventive low dose aspirin medication.   
  • Use of medications, herbs, food supplements, and vitamins known to induce photosensitivity to light exposure at the wavelengths used,
      such as Isotretinoin
  • (Accutane) within the last six months, Tetracyclines, or St. John's Wort within the last two weeks.
  • Patients on systemic corticosteroid therapy six months prior to- and throughout the course of the treatments.
  • As per the practitioner's discretion, refrain from treating any condition which might make it unsafe for the patient.